Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
32.51
+0.59 (1.85%)
At close: Dec 19, 2025, 4:00 PM EST
32.70
+0.19 (0.58%)
After-hours: Dec 19, 2025, 7:59 PM EST
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.99 billion as of December 19, 2025. Its market cap has decreased by -36.12% in one year.
Market Cap
1.99B
Enterprise Value
1.85B
1-Year Change
-36.12%
Ranking
Category
Stock Price
$32.51
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $1.99B, an increase of 433.61%. That is a compound annual growth rate of 26.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.99B | -27.93% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |